Check back for updates on the 2019 ASCO-SITC Clinical Immuno-Oncology Symposium program.

Designed for clinicians, scientists, and all other members of the cancer care and research community, this three-day meeting focuses on the clinical application of scientific advances in immuno-oncology. At the 2019 Symposium, expert faculty will offer new insights on the application of immunotherapy in lung cancer, genitourinary cancers, melanoma and other skin cancers, breast cancer, and gynecologic cancers. Faculty will also discuss the clinical relevance of immunogenomics, T Cell therapies, cancer vaccines, the microbiome, and promising combination strategies.

Each day of the 2019 program will feature a Keynote Lecture given by world-renowned experts on exciting topics in immuno-oncology including genomic analysis for immunotherapy, the future of the field, and T Cell differentiation and exhaustion.

For members of the cancer care team looking for a foundational understanding of immunology, the Symposium will also feature an early morning “Immunology 201” session.

The meeting will also offer several opportunities for robust networking, discussion, and engagement with faculty members and other attendees. Participants in Networking Roundtable sessions will interact with leaders in the field to discuss research and treatment in all of the disease-sites covered by the educational program. During the Trainee and Early-Career Networking Luncheon, faculty will lead small-group discussions on the clinical application of immuno-oncology specifically tailored for early-career attendees.

7:00 AM-7:55 AM Poster Session C
With Complimentary Continental Breakfast
7:55 AM-9:00 AM Welcome and General Session 7: Immunotherapy in Breast and Gynecologic Cancers—Building on Recent Successes
9:05 AM-9:45 AM Keynote Lecture
9:45 AM-10:15 AM Break
11:30 AM-1:00 PM

Poster Session C
With Complimentary Boxed Lunch

11:30 AM-1:00 PM Trials in Progress Poster Session C
11:45 AM-12:45 PM Networking Roundtables
1:00 PM-2:00 PM General Session 8: Targeting the Microbiome in Cancer Therapy
2:00 PM-2:30 PM Break
2:30 PM-4:00 PM General Session 9: Promising Combination Strategies